FluSure XP™: Research-Backed Swine Influenza Virus (SIV) Vaccine for Combating Rapidly Evolving SIV Viruses
Introduction of the H3N2 influenza virus into the US swine population in 1998 has resulted in the emergence of multiple reassortant swine influenza viruses (SIVs) in every geographic region of the country, writes Michael Kuhn, DVM, Pfizer Animal Health.
21 November 2008
2 minute read
